Experimental Ebola Vaccines Well Tolerated, Immunogenic in Phase 2 Study

Two investigational vaccines designed to protect against Ebola virus disease were well-tolerated and induced an immune response among 1,000 … Full Article http://j.gs/5sTq

Click here to read full article